SE9001308L - Foerfarande foer att behandla och foerebygga foertvining av bensubstans - Google Patents

Foerfarande foer att behandla och foerebygga foertvining av bensubstans

Info

Publication number
SE9001308L
SE9001308L SE9001308A SE9001308A SE9001308L SE 9001308 L SE9001308 L SE 9001308L SE 9001308 A SE9001308 A SE 9001308A SE 9001308 A SE9001308 A SE 9001308A SE 9001308 L SE9001308 L SE 9001308L
Authority
SE
Sweden
Prior art keywords
vitamin
alpha
active
treating
dosage ranges
Prior art date
Application number
SE9001308A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9001308D0 (sv
Inventor
H F Deluca
Original Assignee
Bone Care Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc
Publication of SE9001308D0 publication Critical patent/SE9001308D0/xx
Publication of SE9001308L publication Critical patent/SE9001308L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Processing Of Solid Wastes (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Disintegrating Or Milling (AREA)
  • Fertilizers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9001308A 1988-08-02 1990-04-10 Foerfarande foer att behandla och foerebygga foertvining av bensubstans SE9001308L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22737188A 1988-08-02 1988-08-02

Publications (2)

Publication Number Publication Date
SE9001308D0 SE9001308D0 (sv) 1990-04-10
SE9001308L true SE9001308L (sv) 1990-04-10

Family

ID=22852835

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9001308A SE9001308L (sv) 1988-08-02 1990-04-10 Foerfarande foer att behandla och foerebygga foertvining av bensubstans

Country Status (11)

Country Link
EP (1) EP0381750B1 (fr)
JP (1) JP3030854B2 (fr)
AT (1) ATE114471T1 (fr)
AU (1) AU634490B2 (fr)
CA (1) CA1341408C (fr)
DE (1) DE68919673T2 (fr)
GB (1) GB2231794B (fr)
MX (1) MX9203760A (fr)
NL (1) NL8920901A (fr)
SE (1) SE9001308L (fr)
WO (1) WO1990001321A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
JPH0753384A (ja) * 1993-07-13 1995-02-28 Wisconsin Alumni Res Found ２４−エピ−１α−ヒドロキシビタミンＤ２ を含んでなる骨粗鬆症治療剤
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6096876A (en) * 1997-08-06 2000-08-01 Shriners Hospitals For Children 1-α-hydroxylase materials and methods
WO2005077378A1 (fr) * 2004-02-18 2005-08-25 Mercian Corporation Procédé consistant à prévenir, médicamenter et/ou traiter l'hypocalcémie chez un mammifère domestique
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US11752158B2 (en) * 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225596A (en) 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
CH665834A5 (de) * 1983-05-09 1988-06-15 Wisconsin Alumni Res Found Verfahren zur herstellung von 1alpha,25-dihydroxyliertem vitamin d(2) und verwandten verbindungen.
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass

Also Published As

Publication number Publication date
MX9203760A (es) 1992-09-01
GB2231794A (en) 1990-11-28
SE9001308D0 (sv) 1990-04-10
JPH03501388A (ja) 1991-03-28
WO1990001321A2 (fr) 1990-02-22
CA1341408C (fr) 2002-12-10
ATE114471T1 (de) 1994-12-15
JP3030854B2 (ja) 2000-04-10
AU4220389A (en) 1990-03-05
DE68919673T2 (de) 1995-06-01
DE68919673D1 (de) 1995-01-12
AU634490B2 (en) 1993-02-25
WO1990001321A3 (fr) 1990-05-17
EP0381750A1 (fr) 1990-08-16
GB2231794B (en) 1992-01-15
EP0381750B1 (fr) 1994-11-30
NL8920901A (nl) 1990-07-02
GB9006990D0 (en) 1990-08-29

Similar Documents

Publication Publication Date Title
RU94027680A (ru) Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы
RU92004521A (ru) Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения
MY117892A (en) Therapeutic compounds
GEP20032925B (en) Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake
RU95102778A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен
MY111188A (en) Improvements in or relating to benzothiophenes.
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
BR9807675A (pt) Processos para fabricação de um complexo argimina-silicato-inositol, para prevenir ou inibir a arterioesclerose em um indivìduo, para suplementação dietética de arginina, para prevenção da desmineralização de ossos ou degradação de cartilagens em um indivìduo com necessidade do mesmo, para tratamento de um mamìfero para aliviar os efeitos patológicos da osteoporose, osteogenesis imperfecta, fraturas ósseas, osteoartrites e outras doenças de ossos e cartilagens, complexo arginina-silicato-inositol, uso do mesmo, e formulação farmacêutica opositora da desmineralização óssea e inibidora da degradação de cartilagem
EP0401903A3 (fr) Utilisation de vanilloides dans le traitement des maladies ou des troubles respiratoires
SE7612534L (sv) Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
RU95106821A (ru) Циклопептиды, способ их получения, фармацевтическая композиция и способ ее получения
SE9001308D0 (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
RU2003136733A (ru) Пероральное введение паратиреоидного гормона и кальцитонина
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
MX9805441A (es) Compuestos terapeuticos.
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
DK0655251T3 (da) Farmaceutisk præparat til forebyggelse eller behandling af knoglebrud
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69528068D1 (de) Conagenine zur prävention und behandlung von diarrhöe
ES2123057T3 (es) Compuestos de fosfonosulfonato para tratar un metabolismo anormal del calcio y los fosfatos.
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
JPS56103114A (en) Drug for osteoporosis comprising 24r- hydroxycholecalciferol
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
FR2635006B1 (fr) Medicament destine a regulariser les secretions hormonales et a traiter la sterilite

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9001308-7

Format of ref document f/p: F